AI assistant
Gubra A/S — Director's Dealing 2023
Mar 30, 2023
6302_rns_2023-03-30_74627976-2207-4ad0-9097-0ed3fbcdac5a.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Press Release
30 March 2023 09:04:00 CEST
Gubra
Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares
Pursuant to the Market Abuse Regulation article 19, Gubra A/S, CVR no. 30514041 (the "Company") hereby notifies receipt of information of the following transactions made by persons discharging managerial responsibilities in the Company and persons closely associated with them in the Company's shares and other financial instruments linked thereto.
Reference is made to company announcement dated 20 March 2023 related to the publication of a prospectus for its initial public offering and listing of the shares of the Company on Nasdaq Copenhagen A/S and announcement dated 30 March 2023 related to the result of the initial public offering (the "Offering").
Transactions made in connection with the Offering
In connection with Offering, the following transactions have been made by persons discharging managerial responsibilities in the Company and persons closely associated with them in the Company's shares and other financial instruments linked thereto:
| 1. | Details of the person discharging managerial responsibilities/person closely associated | |
|---|---|---|
| a) | Name | NV 2008 HOLDING ApS |
| 2. | Reason for the notification | |
| a) | Position/status | Closely associated person to Niels Vrang, member of the executive management of Gubra A/S |
| b) | Initial notification/Amendment | Initial notification |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Gubra A/S |
| b) | LEI | 254900T17RRFZONO6W53 |
| 4.1 | Details of the transaction(s): |
Gubra
Hørsholm Kongevej 11B
2970 Hørsholm
Press Release
30 March 2023 09:04:00 CEST
gubra
| a) | Description of the financial instrument, type of instrument | Shares | |
|---|---|---|---|
| Identification code | Temporary Purchase Certificates (temporary ISIN: DK0062266557) to be exchanged with shares (permanent ISIN DK0062266474) | ||
| b) | Nature of the transaction | Lending of shares as part of the Offering in connection with the overallotment facility under a share lending agreement | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| DKK 110 | 340,909 | ||
| d) | Aggregated information | ||
| — Aggregated volume | |||
| — Price | Average price per share: DKK 110 | ||
| Total number of shares: 340,909 | |||
| Total price: DKK 37,499,990 | |||
| e) | Date of the transaction | 30 March 2023 | |
| f) | Place of the transaction | Outside a trading venue |
Contacts
Media: Sofia Pitt Boserup, [email protected], +45 4188 9586
Investors: Kristian Borbos, [email protected], +45 3080 8035
About Us
Gubra, founded in 2008 in Denmark, is specialized in pre-clinical contract research services and peptide-based drug discovery within metabolic and fibrotic diseases. Gubra's activities are focused on the early stages of drug development and are organised in two business areas - CRO Services and Discovery & Partnerships (D&P). The two business areas are highly synergistic and create a unique entity capable of generating a steady cash flow from the CRO business while at the same time enjoying biotechnology upside in the form of potential development milestone payments and potential royalties from the D&P business. Gubra has approx. 200 employees and had annual revenue of approx. DKK 200 million in 2022. See www.gubra.dk for more information.
This information is information that Gubra is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2023-03-30 09:04 CEST.
Gubra
Hørsholm Kongevej 11B
2970 Hørsholm